Last reviewed · How we verify

Intralesional Steroid Injection

Services Institute of Medical Sciences, Pakistan · FDA-approved active Small molecule

Intralesional Steroid Injection is a Corticosteroid Small molecule drug developed by Services Institute of Medical Sciences, Pakistan. It is currently FDA-approved for Keloids and hypertrophic scars, Lichen planus, Alopecia areata.

Intralesional steroid injection delivers corticosteroids directly into a localized lesion to suppress local inflammation and immune response.

Intralesional steroid injection delivers corticosteroids directly into a localized lesion to suppress local inflammation and immune response. Used for Keloids and hypertrophic scars, Lichen planus, Alopecia areata.

At a glance

Generic nameIntralesional Steroid Injection
SponsorServices Institute of Medical Sciences, Pakistan
Drug classCorticosteroid
TargetGlucocorticoid receptor
ModalitySmall molecule
Therapeutic areaDermatology
PhaseFDA-approved

Mechanism of action

Corticosteroids work by binding to glucocorticoid receptors in immune cells, suppressing pro-inflammatory cytokine production and reducing local inflammation, edema, and immune cell infiltration. Direct injection into the lesion achieves high local drug concentration while minimizing systemic exposure and side effects.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Intralesional Steroid Injection

What is Intralesional Steroid Injection?

Intralesional Steroid Injection is a Corticosteroid drug developed by Services Institute of Medical Sciences, Pakistan, indicated for Keloids and hypertrophic scars, Lichen planus, Alopecia areata.

How does Intralesional Steroid Injection work?

Intralesional steroid injection delivers corticosteroids directly into a localized lesion to suppress local inflammation and immune response.

What is Intralesional Steroid Injection used for?

Intralesional Steroid Injection is indicated for Keloids and hypertrophic scars, Lichen planus, Alopecia areata, Psoriasis plaques, Lichen sclerosus.

Who makes Intralesional Steroid Injection?

Intralesional Steroid Injection is developed and marketed by Services Institute of Medical Sciences, Pakistan (see full Services Institute of Medical Sciences, Pakistan pipeline at /company/services-institute-of-medical-sciences-pakistan).

What drug class is Intralesional Steroid Injection in?

Intralesional Steroid Injection belongs to the Corticosteroid class. See all Corticosteroid drugs at /class/corticosteroid.

What development phase is Intralesional Steroid Injection in?

Intralesional Steroid Injection is FDA-approved (marketed).

What are the side effects of Intralesional Steroid Injection?

Common side effects of Intralesional Steroid Injection include Local skin atrophy, Telangiectasia (dilated blood vessels), Hypopigmentation or hyperpigmentation, Local pain or burning at injection site, Systemic steroid absorption (minimal with intralesional route).

What does Intralesional Steroid Injection target?

Intralesional Steroid Injection targets Glucocorticoid receptor and is a Corticosteroid.

Related